Insomnia Prevention in Children With Acute Lymphoblastic Leukemia

Insomnia Prevention in Children With Acute Lymphoblastic Leukemia

The goal of this research study is to understand the acceptability and feasibility of the Sleep ALL Night intervention among children with Acute Lymphoblastic Leukemia (ALL) in hopes of improving the discussion of sleep disorders with clinical providers.

The name of the intervention used in this research study is: Sleep ALL Night, which is a sleep intervention program comprised of an action plan tool and psychoeducational website.

This research study is to conduct a single-arm pilot study to determine the acceptability and feasibility of Sleep ALL Night for children with Acute Lymphoblastic Leukemia (ALL).

Participation in this research study is expected to last 1 month.

It is expected about 30 children will take part in this research study.

The National Cancer Institute (NCI) is providing funding for this research study through a grant.

Inclusion Criteria:

• Patient in the Maintenance Phase of therapy on or as per DFCI 16-001 and has completed at least two cycles of maintenance therapy to allow adequate recovery from the more intensive Consolidation phase.
• English or Spanish speaking child and primary caregiver (parent/guardian).
• Child aged 4-12 years.

Exclusion Criteria:

• Primary team declines permission to approach.
• Children with critical illness (defined as ICU admission)